In the last week, the United Kingdom market has stayed flat, though it is up 7.1% over the past year with earnings expected to grow by 14% per annum over the next few years. In light of these conditions, identifying high growth tech stocks can be crucial for investors looking to capitalize on potential future gains in this dynamic sector.

Top 10 High Growth Tech Companies In The United Kingdom

Click here to see the full list of 48 stocks from our UK High Growth Tech and AI Stocks screener.

We’ll examine a selection from our screener results.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Nexxen International Ltd. offers an end-to-end software platform for advertisers to connect with publishers in Israel, with a market cap of £410.40 million.

Operations: Nexxen International Ltd. generates revenue primarily from its marketing services segment, which accounted for $339.02 million. The company’s end-to-end software platform facilitates connections between advertisers and publishers in Israel.

Nexxen International, amidst a transformative phase, has shown promising signs of recovery and strategic prowess. With a recent earnings report highlighting a shift from a net loss of $5.61 million to a net income of $2.92 million in Q2 2024, the company’s financial health is evidently improving. This turnaround is underscored by an 8.8% year-over-year revenue increase to $88.58 million in the same quarter, reflecting robust operational execution despite broader market challenges. Further bolstering its market position, Nexxen has actively repurchased shares worth $3.7 million between May and June 2024, affirming confidence in its trajectory.

Moreover, Nexxen’s strategic partnerships are enhancing its technological edge and market reach; notably, its collaboration with The Trade Desk integrates exclusive ACR data segments for advanced advertising solutions across multiple platforms—a critical move in an era where digital media consumption patterns are rapidly evolving. This initiative not only diversifies Nexxen’s revenue streams but also solidifies its standing in high-growth tech sectors by aligning with contemporary digital transformation trends.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Oxford Biomedica plc, with a market cap of £397.14 million, is a contract development and manufacturing organization dedicated to delivering therapies to patients globally.

Operations: Oxford Biomedica plc specializes in the development and manufacturing of advanced therapies, leveraging its expertise to serve global clients. The company generates revenue through contract services aimed at producing gene and cell therapies.

Oxford Biomedica’s recent performance and strategic moves underscore its potential within the high-growth biotech sector. Despite a net loss reduction to £32.49 million from £47.96 million year-over-year, the firm’s sales surged by 18% to £50.81 million in H1 2024, reflecting robust operational execution and market demand for its gene therapy solutions. The appointment of Lucinda Crabtree as CFO promises enhanced financial strategy, given her extensive background in finance across prominent institutions and biopharmaceuticals. With a projected revenue CAGR of over 35% through 2026 and an anticipated earnings growth rate of 106%, Oxford Biomedica is navigating its path toward profitability amid challenging market conditions, further solidified by their innovative AAV processing techniques discussed in recent special calls.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: The Sage Group plc, along with its subsidiaries, offers technology solutions and services for small and medium businesses across the United States, the United Kingdom, France, and internationally, with a market cap of £10.23 billion.

Operations: Sage Group generates revenue primarily from Europe (£595 million), North America (£1.01 billion), and the United Kingdom & Ireland (£488 million). The company focuses on providing technology solutions and services tailored for small and medium businesses across these regions.

Sage Group’s strategic focus on R&D, with a significant allocation of resources amounting to 15.1% of its earnings, underscores its commitment to innovation within the software industry. This investment has catalyzed advancements in Sage Business Cloud, propelling a robust revenue uptick of 7.9% annually. Recent collaborations, like the one with VoPay, integrate cutting-edge payment technologies into Sage’s platforms, enhancing operational efficiencies for SMBs—a sector that still grapples with outdated financial processes. This synergy not only streamlines payroll systems but also positions Sage at the forefront of financial technology solutions tailored for growing businesses.

Seize The Opportunity

Seeking Other Investments?

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com